Work Here?
About Osmind
Industries
Biotechnology
Healthcare
Company Size
51-200
Company Stage
Series B
Total Funding
$55.4M
Headquarters
San Francisco, California
Founded
2020
Overview
Osmind provides an electronic medical record (EMR) system specifically designed for mental health professionals, including psychiatrists and therapists. The platform features tools for billing, scheduling, patient engagement, and intake forms, all aimed at simplifying the management of mental health practices. It automates the tracking of patient progress through objective and measurement-based tools, making it user-friendly even for those less familiar with technology. Unlike many competitors, Osmind operates on a subscription model while also offering a flat-rate payment processing service for patient credit card transactions, which helps maintain a steady revenue stream. The company's goal is to enhance mental health care access and effectiveness, particularly for patients who have not benefited from traditional treatments, while providing excellent customer support to ensure a smooth transition to their EMR system.
Simplify's Take
What believers are saying
- Increased telehealth adoption boosts demand for Osmind's integrated virtual visit solutions.
- The rise of measurement-based care creates opportunities for Osmind's platform.
- Growing emphasis on precision medicine supports Osmind's personalized treatment capabilities.
What critics are saying
- Emerging EMR platforms with lower costs threaten Osmind's market share.
- Telehealth regulation changes may increase Osmind's operational costs.
- Subscription-based revenue models are vulnerable during economic downturns.
What makes Osmind unique
- Osmind offers an all-in-one EMR system tailored for mental health professionals.
- The platform integrates measurement-based care tools, enhancing patient progress tracking.
- Osmind's collaboration with the APA advances precision treatment in psychiatry.
Help us improve and share your feedback! Did you find this helpful?
Funding
Total Funding
$55.4M
Meets
Industry Average
Funded Over
3 Rounds
Tiger Global
General Catalyst
Y CombinatorIndustry standards
Benefits
Professional Development Budget
Growth & Insights and Company News
6 month growth
↓ -7%1 year growth
↓ -1%2 year growth
↓ -3%SAN FRANCISCO--(BUSINESS WIRE)--Today, Osmind, the leading psychiatric treatment and research platform, announced an innovative collaboration with the American Psychiatric Association (APA) to improve the adoption of measurement-based care (MBC) and precision treatment in psychiatry. This collaboration between Osmind and APA’s PsychPRO registry intends to broaden access to personalized care, improve patient outcomes, generate robust real-world evidence (RWE) and accelerate psychiatry’s evolution to precision medicine. PsychPRO registry is a clinical data registry that enables the collection and analysis of clinical data to advance quality improvement efforts and accelerate research for the psychiatric community. "At Osmind, we emphasize the importance of clinicians participating in evidence-generating medicine to help shape the future of mental health care, especially as the psychiatric field begins to embrace new treatments and precision psychiatry,” said Carlene MacMillan, MD, Chief Medical Officer of Osmind. “Clinicians in private practice juggle many competing demands so it is crucial we make participation both easy and worthwhile to them.". Osmind is integrating a number of APA’s diagnostic and outcomes measures of interest, including the DSM-5-TR Self-Rated Level 1 Cross-Cutting Symptom Measure developed by APA researchers, into its electronic health record (EHR) software
Osmind announces collaboration with the American Psychiatric Association to advance quality psychiatric care and accelerate research.
Starting today, mental health clinicians, practice owners, and researchers have free access to sessions led by the nation's foremost mental health clinicians driving breakthrough medicineSAN FRANCISCO, Dec. 5, 2023 /PRNewswire-PRWeb/ -- Osmind, the public benefit corporation helping clinicians and researchers advance life-saving mental health treatment, today announced its inaugural Breakthrough Mental Health Treatment Forum is now open to virtual attendees. Sessions will focus on mental health treatment research, how to build a successful practice, and the value of community in delivering care. The forum brings together psychiatrists, nurse practitioners, psychotherapists, scientists, clinicians, mental health practice leaders and administrators, and academics all dedicated to advancing therapeutic options for people facing severe and treatment-resistant mental illness."The mental health crisis continues to grow, yet critical advancements in psychiatric treatment are lagging behind," said Lucia Huang, co-founder and CEO of Osmind. "This forum is a unique space for those on the leading edge of novel therapeutic care to hear from leaders driving future innovations on the frontlines of breakthrough mental health care, helping more patients access effective care, and supporting future collaborations."The three-day forum will run from Tuesday, December 5 through Thursday, December 7. Content is available asynchronously
Osmind, the public benefit corporation helping clinicians and researchers advance life-saving mental health treatment, today announced Osmind Claims, which introduces new billing capabilities purpose-built to simplify insurance reimbursement for psychiatric treatment, enabling greater access to insurance-supported mental health care.
That’s why Osmind Inc. is proud to announce the launch of its Community Advisory Board (CAB)!
Osmind is Hiring for 3 Jobs on Simplify!
Find jobs on Simplify and start your career today
About Osmind
Industries
Biotechnology
Healthcare
Company Size
51-200
Company Stage
Series B
Total Funding
$55.4M
Headquarters
San Francisco, California
Founded
2020
Osmind is Hiring for 3 Jobs on Simplify!
Find jobs on Simplify and start your career today